Conclusion of non-exclusive discount agreements for medicinal products containing liraglutide under an open-house model

Summary

The tender concerns non-exclusive discount agreements for medicines containing liraglutide under an open-house model. Any interested pharmaceutical company may join during the participation period if it meets the participation conditions and accepts the contract terms. There is no individual negotiation and no delivery exclusivity. The exact participation documents are available in the tender documents; access to the project room is required first. The notice also states that the bidder must be a pharmaceutical entrepreneur for the offered medicines and must submit declarations on exclusion grounds and Russia sanctions compliance.